Profile: Milestone Pharmaceuticals Inc. is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Our lead product is a potent, short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina. We also design and synthesize a limited number of compounds with the desired therapeutic activity & pharmacokinetic properties.